Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare Biotechnology

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc

Bullboard Posts

Comment by peter75on Jan 26, 2018 11:37am

103 Views

Post# 27441064

RE:RE:RE:RE:RE:OK - I think that's it for a while

With an aging population who have doe , they want dividend
i know manyThat are overpaying for pipelines and banks along with reits
they don't look at share price , they only want the monthly distribution

goofman should know this
paying a three and one half percent dividend would a ton to the share price allowing more capital to be lent out at ten percent plus to good start ups

this is why I stay, because an activist investor is going to get on this

i should not say this but it's in the cards as I speak

this company has hedge funds in Boston salivating over the opp. Why do you think I have not sold?

Bullboard Posts

The top 10 Canadian medical stocks